Burden of illness in multiple sclerosis (DEFENSE) study: the costs and quality-of-life of Finnish patients with multiple sclerosis.
Ruutiainen J, Viita AM, Hahl J et al.
Finnish Neuro Society, Masku, Finland.
J Med Econ 2016;19:21–33.
Melinda Magyari’s review: This retrospective, cross-sectional study conducted in Finland confirms the finding in previous studies from other countries that multiple sclerosis (MS) is an expensive disease and that many of the costs are associated with disability. Finland is a country with a high incidence of MS, and the investigators aimed to estimate the economic and health-related quality of life (HRQoL) burden imposed by MS on people with the disease and on the rest of society. The study surveyed a population of patients who were registered with the Finnish Neuro Society, which is a national patient association in Finland.